Skip to content

Clinical study for the relationship between autoimmune thyroid disease and intestinal flora

Clinical study for the relationship between autoimmune thyroid disease and intestinal flora

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021642
Enrollment
Unknown
Registered
2019-03-02
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Thyroid Disease

Interventions

Hashimoto thyroiditis with hyperthyroidism group: Nil
Control group:Nil

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 years to 65 years, male and female; (2) Graves' disease group: newly diagnosed patients with Graves' disease;Hashimoto thyroiditis with hyperthyroidism group: newly diagnosed hashimoto thyroiditis with hyperthyroidism patients;Control group: subjects with normal thyroid function and thyroid autoantibodies; (3) No anti-thyroid medication was taken before enrollment; (4) Willing to participate and cooperate with doctors to carry out the study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Three months using a variety of antibiotics for more than 3 days , used prebiotics, probiotics or lactic acid products within 4 weeks prior to enrollment; (2) Previous treatment with anti-thyroid drugs; (3) With a history of over 2 years of alcohol abuse,perennial smoking history; (4) Pregnancy or lactation; (5) Suspected or proven substance abuse; (6) Oral, respiratory and gastrointestinal diseases; (7) With a variety of metabolic diseases, such as obesity, lipid imbalance, body mass index >27, hypertension, diabetes, stones, various liver diseases etc.; (8) With other autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease SLE etc.; (9) History of gastrointestinal surgery, or other recent surgical history; (10) Family history, history of mental illness, etc.; (11) The subjects are participating in other research projects; (12) The researchers believe that not suitable to participate in clinical trails or complete researchers.

Design outcomes

Primary

MeasureTime frame
Diversity of intestinal flora;Intestinal flora abundance;Free triiodothyronine;Free thyroxine;Serum thyrotropin;Thyrotropin receptor antibody;Thyroglobulin antibody;Thyroid peroxidase antibody;Immune-related factor;Metabolomics;

Countries

China

Contacts

Public ContactJixiong Xu

The First Affiliated Hospital of Nanchang University

xujixiong@163.com+86 13307086069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026